DiaMedica Therapeutics

DiaMedica prepares to end 10-month FDA hold on late-phase stroke trial by halving dose
Fierce Biotech
Tue, 05/16/23 - 12:49 pm
DiaMedica Therapeutics
FDA
clinical trials
stroke
DiaMedica Ischemic Stroke Program Remains on Hold with Plans for Additional Studies
BioSpace
Thu, 10/27/22 - 10:53 am
DiaMedica Therapeutics
DM199
acute ischemic stroke
DiaMedica pulls off IPO to fund midphase stroke trial
Fierce Biotech
Fri, 12/7/18 - 10:44 am
IPOs
DiaMedica Therapeutics
chronic kidney disease
acute ischemic stroke